Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Class A Common Stock
Symbol
DNA on NYSE
Shares outstanding
48,809,163
Price per share
$9.71
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
32,523,350
Total reported value
$270,288,054
% of total 13F portfolios
0%
Share change
+2,323,171
Value change
+$17,760,492
Number of holders
176
Price from insider filings
$9.71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Shetty Reshma P. 9.5% $34,804,700 4,716,084 Reshma P. Shetty 14 Feb 2025
CASCADE INVESTMENT, L.L.C. 7.5% $52,803,453 3,621,636 Cascade Investment, L.L.C. 30 Sep 2025
BlackRock, Inc. 6.5% $33,768,484 3,001,643 BlackRock, Inc. 30 Jun 2025
BAILLIE GIFFORD & CO 4.9% $19,874,603 2,391,649 BAILLIE GIFFORD & CO 31 Dec 2025
VANGUARD GROUP INC 5.1% +17% $26,787,544 +$4,135,129 2,381,115 +18% The Vanguard Group 30 Jun 2025
Che Austin 5% $17,509,589 2,372,573 Austin Che 31 Dec 2024

As of 31 Dec 2025, 176 institutional investors reported holding 32,523,350 shares of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA). This represents 67% of the company’s total 48,809,163 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 7.3% 3,577,128 0% 0.08% $29,725,934
BlackRock, Inc. 7.3% 3,573,369 +4.5% 0% $29,694,696
VANGUARD GROUP INC 5.9% 2,900,952 +17% 0% $24,106,911
BAILLIE GIFFORD & CO 4.9% 2,391,649 -26% 0.02% $19,874,603
Erste Asset Management GmbH 4.1% 2,000,000 -9.1% 0.14% $16,620,000
Anchorage Capital Group, L.L.C. 3.6% 1,746,363 0% 16% $14,512,277
Legal & General Group Plc 3.2% 1,577,927 -1.9% 0% $13,112,572
STATE STREET CORP 2.6% 1,292,071 +38% 0% $10,737,110
FORBES J M & CO LLP 2.1% 1,040,441 -1.9% 0.7% $8,646,065
GEODE CAPITAL MANAGEMENT, LLC 2% 999,600 +24% 0% $8,308,557
GOLDMAN SACHS GROUP INC 1.9% 919,309 +11% 0% $7,639,458
MORGAN STANLEY 1.6% 766,487 +139% 0% $6,369,507
SB INVESTMENT ADVISERS (UK) LTD 1.3% 610,729 0% 0.05% $5,075,158
BANK OF AMERICA CORP /DE/ 1.2% 602,576 -44% 0% $5,007,407
Prescott Group Capital Management, L.L.C. 1.1% 541,845 0.42% $4,502,732
UBS Group AG 1% 489,418 +86% 0% $4,067,064
Allianz Asset Management GmbH 0.92% 449,788 +134% 0% $3,737,738
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.73% 358,295 +4.3% 0% $2,977,431
EXCHANGE TRADED CONCEPTS, LLC 0.72% 349,793 +5.3% 0.02% $2,906,780
Ensign Peak Advisors, Inc 0.68% 330,323 -1.4% 0% $2,744,984
NORTHERN TRUST CORP 0.64% 313,275 -3.8% 0% $2,603,315
Coastal Bridge Advisors, LLC 0.57% 276,817 0% 0.17% $2,300,349
Invesco Ltd. 0.54% 261,706 +24% 0% $2,174,777
Lingotto Investment Management LLP 0.51% 250,282 0% 0.04% $2,079,843
JACOBS LEVY EQUITY MANAGEMENT, INC 0.5% 244,419 +245% 0.01% $2,031,122

Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 32,523,350 $270,288,054 +$17,760,492 $8.31 176
2025 Q3 30,191,452 $437,213,077 -$36,393,787 $14.58 172
2025 Q2 33,351,676 $375,205,711 +$29,774,145 $11.25 164
2025 Q1 32,270,574 $183,952,552 -$9,250,058 $5.70 161
2024 Q4 32,503,442 $318,897,469 +$61,080,938 $9.82 159
2024 Q3 26,309,917 $214,342,391 +$204,195,165 $8.15 146
2024 Q2 12,000 $4,012 +$4,012 $0.33 1